1 김석원, "국내 학회지에 실린 무작위임상시험논문의 양적 분석 및 질 평가 - 5개 학회지를 대상으로" 대한가정의학회 25 (25): 118-125, 2004
2 Hollis S, "What is meant by intention to treat analysis? Survey of published randomised controlled trials" 319 : 670-74, 1999
3 Egger M, "Value of flow diagrams in reports of randomized controlled trials" 285 : 1996-1999, 2001
4 Moher D, "Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation" 285 : 1992-1995, 2001
5 Fergusson D, "Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials" 328 : 432-, 2004
6 Mills EJ, "The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement" 26 : 480-487, 2005
7 Scherer RW, "Reporting of randomized clinical trial descriptors and use of structured abstracts" 280 : 269-272, 1998
8 Piaggio G, "Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement" 295 : 1152-1160, 2006
9 Nuovo J, "Reporting number needed to treat and absolute risk reduction in randomized controlled trials" 287 : 2813-214, 2002
10 Devereaux PJ, "Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials" 285 : 2000-2003, 2001
1 김석원, "국내 학회지에 실린 무작위임상시험논문의 양적 분석 및 질 평가 - 5개 학회지를 대상으로" 대한가정의학회 25 (25): 118-125, 2004
2 Hollis S, "What is meant by intention to treat analysis? Survey of published randomised controlled trials" 319 : 670-74, 1999
3 Egger M, "Value of flow diagrams in reports of randomized controlled trials" 285 : 1996-1999, 2001
4 Moher D, "Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation" 285 : 1992-1995, 2001
5 Fergusson D, "Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials" 328 : 432-, 2004
6 Mills EJ, "The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement" 26 : 480-487, 2005
7 Scherer RW, "Reporting of randomized clinical trial descriptors and use of structured abstracts" 280 : 269-272, 1998
8 Piaggio G, "Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement" 295 : 1152-1160, 2006
9 Nuovo J, "Reporting number needed to treat and absolute risk reduction in randomized controlled trials" 287 : 2813-214, 2002
10 Devereaux PJ, "Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials" 285 : 2000-2003, 2001
11 Campbell MJ, "Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons" 311 : 1145-1148, 1995
12 Altman DG, "Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors" 330 : 1056-1057, 2005
13 Chan AW, "Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles" 291 : 2457-2465, 2004
14 Schulz KF, "Emperical evidence of bias. Dimentions of methodological quality associated with estimates of treatment effects in controlled trials" 273 : 408-412, 1995
15 Godlee F, "Effect on the quality of peer review of blinding reviewers and asking them to sign their reports: a randomized controlled trial" 280 : 237-240, 1998
16 Berlin JA, "Does blinding of readers affect the results of meta-analyses? University of Pennsylvania. Meta-analysis Blinding Study Group" 350 : 185-186, 1997
17 Clarke M, "Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents?" 280 : 280-282, 1998
18 Clarke M, "Discussion sections in reports of controlled trials published in general medical journals" 287 : 2799-2801, 2002
19 Ioannidis JP, "Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas" 285 : 437-443, 2001
20 Campbell MK, "CONSORT statement: extension to cluster randomised trials" 328 : 702-708, 2004
21 Altman DG, "CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration" 134 : 663-694, 2001
22 Moher D, "CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials" 285 : 1987-1991, 2001
23 Ioannidis JP, "CONSORT Group. Better reporting of harms in randomized trials: an extension of the CONSORT statement" 141 : 781-788, 2004
24 Schulz KF, "Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology" 312 : 742-744, 1996
25 Kim CB, "Assessment on quality improvement of the abstracts of the original research articles in the korean journal of preventive medicine" 36 : 179-186, 2003